Global Medical Implants Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Product;

Cardiovascular Implants, Orthopedic Implants, Dental Implants, Facial Implants, and Breast Implants.

By Material;

Metallic Biomaterials, Ceramic Biomaterials, Polymers Biomaterials and Natural Biomaterials.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn589710825 Published Date: March, 2025 Updated Date: May, 2025

Introduction

Global Medical Implants Market (USD Million), 2021 - 2031

In the year 2024, the Global Medical Implants Market was valued at USD 92,352.20 million. The size of this market is expected to increase to USD 148,783.22 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

The Global Medical Implants Market is witnessing dynamic growth, fueled by technological advancements, rising chronic disease cases, and increasing demand for both therapeutic and cosmetic implants. These devices whether placed internally or externally—are crucial in enhancing patient recovery, restoring functionality, and improving health outcomes across multiple specialties, including orthopedics, cardiology, neurology, and dentistry.

With over 60% of manufacturers now leveraging biocompatible materials, smart features, and less invasive procedures, innovation is a driving force in the industry. The movement toward personalized treatment is accelerating, as around 35% of new implants are tailored to individual anatomical and physiological needs. This customization is boosting acceptance rates, especially in orthopedic and dental procedures.

Cardiovascular implants, such as pacemakers and stents, currently represent nearly 30% of the total market, driven by the rising burden of heart-related conditions and a surge in minimally invasive cardiac surgeries. Meanwhile, orthopedic implants maintain the largest market share at over 40%, reflecting the impact of an aging population and increased demand for mobility-restoring solutions.

Outpatient and ambulatory implant surgeries have grown significantly, now accounting for about 25% of all implant procedures. Enhanced insurance access, smarter postoperative monitoring tools, and shorter recovery periods are propelling this shift. As patient preferences evolve, the market is pivoting toward implant solutions that offer enhanced performance, durability, and clinical value.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product
    2. Market Snapshot, By Material
    3. Market Snapshot, By Region
  4. Global Medical Implants Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Technological Advancements

        2. Aging Population

        3. Rising Healthcare Expenditure

      2. Restraints
        1. High Cost

        2. Reimbursement Issues

        3. Complications Risks

      3. Opportunities
        1. Personalized Implants

        2. Minimally Invasive Procedures

        3. Expanding Applications

    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Medical Implants Market, By Product, 2021 - 2031 (USD Million)
      1. Cardiovascular Implants

      2. Orthopedic Implants

      3. Dental Implants

      4. Facial implants

      5. Breast implants

    2. Global Medical Implants Market, By Material, 2021 - 2031 (USD Million)
      1. Metallic Biomaterials

      2. Ceramic Biomaterials

      3. Polymers Biomaterials

      4. Natural Biomaterials

    3. Global Medical Implants Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Zimmer Biomet
      2. CONMED Corporation
      3. Boston Scientific Corporation
      4. Stryker
      5. Smith+Nephew
  7. Analyst Views
  8. Future Outlook of the Market